Cargando…
Human and Machine Intelligence Together Drive Drug Repurposing in Rare Diseases
Repurposing is an increasingly attractive method within the field of drug development for its efficiency at identifying new therapeutic opportunities among approved drugs at greatly reduced cost and time of more traditional methods. Repurposing has generated significant interest in the realm of rare...
Autores principales: | Challa, Anup P., Zaleski, Nicole M., Jerome, Rebecca N., Lavieri, Robert R., Shirey-Rice, Jana K., Barnado, April, Lindsell, Christopher J., Aronoff, David M., Crofford, Leslie J., Harris, Raymond C., Alp Ikizler, T., Mayer, Ingrid A., Holroyd, Kenneth J., Pulley, Jill M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8355705/ https://www.ncbi.nlm.nih.gov/pubmed/34394194 http://dx.doi.org/10.3389/fgene.2021.707836 |
Ejemplares similares
-
Systematically Prioritizing Candidates in Genome-Based Drug Repurposing
por: Challa, Anup P., et al.
Publicado: (2019) -
Rule-based and machine learning algorithms identify patients with systemic sclerosis accurately in the electronic health record
por: Jamian, Lia, et al.
Publicado: (2019) -
Phenome-wide association study identifies marked increased in burden of comorbidities in African Americans with systemic lupus erythematosus
por: Barnado, April, et al.
Publicado: (2018) -
The Astounding Breadth of Health Disparity: Phenome-Wide Effects of Race on Disease Risk
por: Pulley, Jill M., et al.
Publicado: (2020) -
Medication history-wide association studies for pharmacovigilance of pregnant patients
por: Challa, Anup P., et al.
Publicado: (2022)